These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11399815)

  • 81. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors.
    Hans R; Sharma RR; Marwaha N
    Asian J Transfus Sci; 2019; 13(1):10-16. PubMed ID: 31360004
    [TBL] [Abstract][Full Text] [Related]  

  • 83. T-cell lymphopenia in frequent volunteer platelet donors.
    Kaufman RM
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):305-310. PubMed ID: 38066852
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
    Williams D; Rao M; Carey P
    J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The post-platelet 100,000 count: effects of platelet collection and future.
    Jaben EA; Gandhi MJ
    J Clin Apher; 2011; 26(1):53-5. PubMed ID: 21312259
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lymphocytopenia in donors undergoing regular platelet apheresis with cell separators.
    Robbins G; Petersen CV; Brozović B
    Clin Lab Haematol; 1985; 7(3):225-30. PubMed ID: 4075737
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.
    Sumner SM; Naskou MC; Thoresen M; Copland I; Peroni JF
    Transfusion; 2017 Jul; 57(7):1755-1762. PubMed ID: 28439897
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis.
    Unay Demirel O; Ignak S; Buyukuysal MC
    Indian J Hematol Blood Transfus; 2018 Oct; 34(4):684-690. PubMed ID: 30369741
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
    Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
    Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors.
    Kim HJ; Kim NC; Park CW
    Vox Sang; 2008 Jul; 95(1):45-51. PubMed ID: 18380771
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Frequent multiunit plateletpheresis from single donors: effects on donors' blood and the platelet yield.
    Glowitz RJ; Slichter SJ
    Transfusion; 1980; 20(2):199-205. PubMed ID: 7368268
    [No Abstract]   [Full Text] [Related]  

  • 92. Changes in pre- and post-donation platelet function in plateletpheresis donors.
    Zhou Q; Yu X; Cai Y; Liu L
    Transfus Clin Biol; 2017 Nov; 24(4):417-421. PubMed ID: 28599950
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India.
    Sahoo D; Noushad S; Basavarajegowda A; Toora E
    Asian J Transfus Sci; 2023; 17(1):34-40. PubMed ID: 37188018
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Plateletpheresis with the new cell separator A 201 (Baxter)].
    Luboldt W; Moog R
    Beitr Infusionsther; 1991; 28():195-200. PubMed ID: 1725618
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of double dose plateletpheresis on target yield and donor platelet recovery.
    Chopra S; Kaur P; Bedi RK; Kaur G
    Hematol Transfus Cell Ther; 2023; 45(1):16-24. PubMed ID: 34294601
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Aggregates in apheresis-derived platelet concentrates: A 5-year single-centre experience.
    Vinković M; Hećimović A; Jukić I; Vuk T
    Vox Sang; 2024 Jul; 119(7):686-692. PubMed ID: 38629266
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
    Gupta AM; Bajpai M
    J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
    Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
    Kaufman RM; Marks DC; Flamand Y; Acker JP; Brown BL; Olafson C; Marschner S; Pandey S; Papari M; Petraszko T; Serrano K; Ward D; Bazin R;
    Transfusion; 2023 Nov; 63(11):2072-2082. PubMed ID: 37818894
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Genetic variations of CD36 and low platelet CD36 expression - a risk factor for lipemic plasma donation in Taiwanese apheresis donors.
    Lo SC; Lin KH; Hsieh HH; Lin DT; Hu CY
    Vox Sang; 2016 Apr; 110(3):236-43. PubMed ID: 26528880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.